Fighting Patient Infection
Rapid, Sensitive, and Affordable Testing
Sept 2011 – US patent issued: “Rapid and sensitive detection of cells and viruses”, Pat. Number US 8021848
March 2011 – First Light awarded a $3M 3 year Phase II NIH SBIR grant to develop an benchtop automated platform for hospital clinical microbiology laboratories that rapidly, affordably, and sensitively detects the microbes that cause hospital infections including resistant (MRSA) and sensitive
June 2010 – European patent granted: “Rapid and sensitive detection of molecules”, Pat. Number 1428010.
September 2009 - Filed patent applications for consumables, methods, and instrumentation.
March 2009 – First Light awarded a $3M 3 year Phase II NIH SBIR grant to develop an automated platform to accommodate the surge in testing that would occur following a large biowarfare attack or infectious disease outbreak.
September 2008 – First Light awarded a $600K 2 year NIH Phase I SBIR grant to develop the MultiPath imaging technology for rapid, sensitive, and low-cost detection of resistant (MRSA) and sensitive
August 2008 – First Light awarded a $300K NIH Phase I SBIR grant to develop the MultiPath imaging technology for highly sensitive detection of respiratory viruses and to develop a very easy to use instrument model.
First Light Biosciences
1 Oak Park Drive, Floor 2
Bedford MA, 01730
(781) 271 0112
© First Light Biosciences - All Rights Reserved